0001209191-20-059061.txt : 20201118
0001209191-20-059061.hdr.sgml : 20201118
20201118161318
ACCESSION NUMBER: 0001209191-20-059061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201117
FILED AS OF DATE: 20201118
DATE AS OF CHANGE: 20201118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexander Robert
CENTRAL INDEX KEY: 0001608782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38268
FILM NUMBER: 201325198
MAIL ADDRESS:
STREET 1: 508 WRANGLER DRIVE, SUITE 100
CITY: COPPELL
STATE: TX
ZIP: 75019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allena Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001624658
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452729920
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE NEWTON EXECUTIVE PARK
STREET 2: SUITE 202
CITY: NEWTON
STATE: MA
ZIP: 02462
BUSINESS PHONE: 617-467-4577
MAIL ADDRESS:
STREET 1: ONE NEWTON EXECUTIVE PARK
STREET 2: SUITE 202
CITY: NEWTON
STATE: MA
ZIP: 02462
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-17
0
0001624658
Allena Pharmaceuticals, Inc.
ALNA
0001608782
Alexander Robert
C/O ALLENA PHARMACEUTICALS, INC.
ONE NEWTON EXECUTIVE PARK, SUITE 202
NEWTON
MA
02462
1
0
0
0
Stock Option (Right to Buy)
1.45
2020-11-17
4
A
0
14000
0.00
A
2030-11-16
Common Stock
14000
14000
D
Stock option shall vest in full (i.e., in single installment) upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting of shareholders.
/s/ Kevin Brennan, attorney-in-fact
2020-11-18